Evidence map›Paper›PMID 40452267›Full record

Trial reportClinical obesity2025

Impact of weight on daily activities questionnaire in patients with overweight or obesity: Psychometric evaluation using data from the OASIS 1 trial.

Lisa von Huth Smith, Diane Whalley, Stuart Yarr, Jonathan Comins, Sheri E Fehnel

Registry-linked trialAbstract readClinical Trial, Phase IIIMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Clinical obesity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT05035095. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05035095 phase3completed

Efficacy and Safety of Oral Semaglutide 50 mg Once Daily in Subjects With Overweight or Obesity (OASIS 1)

Ran2021Enrolled667Registered outcomes29Posted comparisons4ConditionsObesity, OverweightArmsOral semaglutide, Placebo (semaglutide)
PMID 37385278other papers from this trial
Open the trial in the graph
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lisa von Huth SmithNovo Nordisk A/S, Søborg, Denmark.
Diane WhalleyPatient-Centered Outcomes Assessment, RTI Health Solutions, Towers Business Park, Manchester, UK.
Stuart YarrPatient-Centered Outcomes Assessment, RTI Health Solutions, Towers Business Park, Manchester, UK.
Jonathan CominsNovo Nordisk A/S, Søborg, Denmark.
Sheri E FehnelPatient-Centered Outcomes Assessment, RTI Health Solutions, Research Triangle Park, North Carolina, USA.

Funding

Novo Nordisk A/S 0306949
6 · The paper itself

Abstract

The Impact of Weight on Daily Activities Questionnaire (IWDAQ) is a patient-reported outcome measure that uses a novel, adaptive design to assess the limitations in daily activities that are most important to individuals attempting to lose weight. During the first round of completing the IWDAQ, respondents are presented with 18 everyday activities that can be limited by excess weight and asked to choose the three activities they would most like to see improve with weight loss. They are then asked to rate the degree of limitation they experience with these three activities at baseline and at follow-up assessments. Using data from a weight-management clinical trial (OASIS 1, NCT05035095), we evaluated the IWDAQ's measurement properties, determined optimal scoring, and estimated thresholds of meaningful within-patient change. Our analyses demonstrated that the IWDAQ Composite Score offers a reliable and valid personalized measure of limitations in daily activities due to excess weight. The adaptive design of the IWDAQ ensures the patient-centricity of the measure, thereby complementing existing measures of functioning in the context of weight-management clinical trials. Evaluations using data from additional studies would be valuable in extending the psychometric evidence for the IWDAQ.

Indexed as

Activities of Daily LivingObesityOverweightAdultBody WeightFemaleHumansMaleMiddle AgedPatient Reported Outcome MeasuresPsychometricsReproducibility of ResultsSurveys and QuestionnairesWeight Lossdaily activitiespatient‐reported outcomepsychometricsemaglutideweight loss

Identifiers

PMID40452267
PMCPMC12289406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.